GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » E10

Ibnsina Pharma (CAI:ISPH) E10 : E£0.22 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ibnsina Pharma's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was E£0.490. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is E£0.22 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-01), Ibnsina Pharma's current stock price is E£ 8.87. Ibnsina Pharma's E10 for the fiscal year that ended in Dec. 2024 was E£0.22. Ibnsina Pharma's Shiller PE Ratio of today is 40.32.

During the past 10 years, the highest Shiller PE Ratio of Ibnsina Pharma was 40.32. The lowest was 27.95. And the median was 30.45.


Ibnsina Pharma E10 Historical Data

The historical data trend for Ibnsina Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma E10 Chart

Ibnsina Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.22

Ibnsina Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.22

Competitive Comparison of Ibnsina Pharma's E10

For the Medical Distribution subindustry, Ibnsina Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibnsina Pharma's Shiller PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's Shiller PE Ratio falls into.


;
;

Ibnsina Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ibnsina Pharma's adjusted earnings per share data for the fiscal year that ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.49/133.1571*133.1571
=0.490

Current CPI (Dec. 2024) = 133.1571.

Ibnsina Pharma Annual Data

per_share_eps CPI Adj_EPS
201512 0.055 99.792 0.073
201612 0.098 101.863 0.128
201712 0.142 104.011 0.182
201812 0.220 105.998 0.276
201912 0.240 108.420 0.295
202012 0.163 109.897 0.197
202112 0.260 117.630 0.294
202212 0.130 125.222 0.138
202312 0.170 129.419 0.175
202412 0.490 133.157 0.490

Add all the adjusted EPS together and divide 10 will get our e10.


Ibnsina Pharma  (CAI:ISPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ibnsina Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.87/0.22
=40.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Shiller P/E Ratio of Ibnsina Pharma was 40.32. The lowest was 27.95. And the median was 30.45.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ibnsina Pharma E10 Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibnsina Pharma Business Description

Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma Headlines

No Headlines